6 Results

People

  1. Adel
    Adel
  2. Lendvai
    Lendvai
  3. Chung
    Chung
  4. Devlin
    Devlin
  5. Giralt
    Giralt
  6. Hassoun
    Hassoun
  7. Landau
    Landau
  8. Landgren
    Landgren
  9. Lesokhin
    Lesokhin
  10. Afifi
    Afifi

Groups

  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies Research (6)
  4. Hematologic Malignancies, Division of (6)
  5. Myeloma (6)
  6. Biostatistics Service (5)
  7. Bone Marrow Transplant (5)
  8. Epidemiology and Biostatistics (5)
  9. Survivorship Research (5)
  10. Clinical Pharmacy Specialists (1)
  1. "Nelly Adel"
  2. "Center for Hematologic Malignancies"
  3. "Nikoletta Lendvai"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies Research (6)
  4. Hematologic Malignancies, Division of (6)
  5. Myeloma (6)
  6. Biostatistics Service (5)

More Groups

People
  1. Nelly Adel (6)
  2. Nikoletta Lendvai (6)
  3. Alexander Lesokhin (5)
  4. Carl Landgren (5)
  5. David Chung (5)
  6. Hani Hassoun (5)

More People

Years
  1. 2016 (1)
  2. 2015 (1)
  3. 2014 (3)
  4. 2013 (1)
Publications
  1. Blood (4)
  2. Bone Marrow Transplantation (2)
Publishers
  1. American Society of Hematology (4)
  2. Nature Publishing Group (2)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: Efficacy and cost analysis study
    Journal Article

    Afifi, S.; Adel, N. G.; Devlin, S.; Duck, E.; Vanak, J.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Korde, N.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Incidence and management of proteasome inhibitor-related cardiotoxicity in multiple myeloma patients at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Land, J.; Afifi, S.; Adel, N. G.; Devlin, S.; Arora, A.; Lendvai, N.; Landgren, O.
    Blood (2015)

    Fulltext@MSK | Save
  • Efficacy and risk factors analysis of upfront autologous stem cell mobilization using plerixafor and granulocyte-colony stimulating factor (GCSF) in patients with multiple myeloma
    Meeting Abstract

    Ogunniyi, A.; Rodriguez, M.; Devlin, S. M.; Adel, N. G.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Analysis of VDT-PACE utilization in multiple myeloma patients treated at MSKCC for relapsed disease or cytoreduction and stem cell mobilization after initial induction therapy
    Meeting Abstract

    Beyer, K.; Rosner, S.; Woo, K. M.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lendvai, N.; Chung, D. J.; Adel, N. G.; Puto, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients: An update on cost analysis study at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Duck, E.; Devlin, S. M.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Chung, D. J.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: Experience at Memorial Sloan Kettering Cancer Center
    Journal Article

    Pozotrigo, M.; Adel, N.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Riedel, E.; Chen, X.; Reich, L.; more...
    Bone Marrow Transplantation (2013)

    Fulltext@MSK | Save